Cargando…
A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough
Statins alone are not always adequate therapy to achieve low-density lipoprotein (LDL) goals in many patients. Many options are available either alone or in combination with statins that makes it possible to reach recommended goals in a safe and tolerable fashion for most patients. Ezetimibe and bil...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252497/ https://www.ncbi.nlm.nih.gov/pubmed/22109348 http://dx.doi.org/10.1007/s11883-011-0222-z |
_version_ | 1782220637658415104 |
---|---|
author | Shanes, Jeffrey G. |
author_facet | Shanes, Jeffrey G. |
author_sort | Shanes, Jeffrey G. |
collection | PubMed |
description | Statins alone are not always adequate therapy to achieve low-density lipoprotein (LDL) goals in many patients. Many options are available either alone or in combination with statins that makes it possible to reach recommended goals in a safe and tolerable fashion for most patients. Ezetimibe and bile acid sequestrants reduce cholesterol transport to the liver and can be used in combination. Niacin is very effective at lowering LDL, beyond its ability to raise high-density lipoprotein and shift LDL particle size to a less atherogenic type. When statins cannot be tolerated at all, red yeast rice can be used if proper formulations of the product are obtained. Nutrients can also be added to the diet, including plant stanols and sterols, soy protein, almonds, and fiber, either individually or all together as a portfolio diet. A clear understanding of how each of these strategies works is essential for effective results. |
format | Online Article Text |
id | pubmed-3252497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Current Science Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-32524972012-01-20 A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough Shanes, Jeffrey G. Curr Atheroscler Rep Statin Drugs (M Clearfield, Section Editor) Statins alone are not always adequate therapy to achieve low-density lipoprotein (LDL) goals in many patients. Many options are available either alone or in combination with statins that makes it possible to reach recommended goals in a safe and tolerable fashion for most patients. Ezetimibe and bile acid sequestrants reduce cholesterol transport to the liver and can be used in combination. Niacin is very effective at lowering LDL, beyond its ability to raise high-density lipoprotein and shift LDL particle size to a less atherogenic type. When statins cannot be tolerated at all, red yeast rice can be used if proper formulations of the product are obtained. Nutrients can also be added to the diet, including plant stanols and sterols, soy protein, almonds, and fiber, either individually or all together as a portfolio diet. A clear understanding of how each of these strategies works is essential for effective results. Current Science Inc. 2011-11-23 2012 /pmc/articles/PMC3252497/ /pubmed/22109348 http://dx.doi.org/10.1007/s11883-011-0222-z Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Statin Drugs (M Clearfield, Section Editor) Shanes, Jeffrey G. A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough |
title | A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough |
title_full | A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough |
title_fullStr | A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough |
title_full_unstemmed | A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough |
title_short | A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough |
title_sort | review of the rationale for additional therapeutic interventions to attain lower ldl-c when statin therapy is not enough |
topic | Statin Drugs (M Clearfield, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252497/ https://www.ncbi.nlm.nih.gov/pubmed/22109348 http://dx.doi.org/10.1007/s11883-011-0222-z |
work_keys_str_mv | AT shanesjeffreyg areviewoftherationaleforadditionaltherapeuticinterventionstoattainlowerldlcwhenstatintherapyisnotenough AT shanesjeffreyg reviewoftherationaleforadditionaltherapeuticinterventionstoattainlowerldlcwhenstatintherapyisnotenough |